XWResearcher profile · from public sources
Xiuchao Wang
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 trial.
Signal transduction and targeted therapy, Nov 2026
Publication
Cancer cell-specific FOXP3 licenses MMP19-dependent matrix remodeling and metastatic dissemination in pancreatic ductal adenocarcinoma.
Oncogene, Oct 2026
Publication
Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.
Cancer discovery, Aug 2026
Publication
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.
Signal transduction and targeted therapy, Apr 2026
Publication
Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), Jan 2026
Publication
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.
Nature communications, Jan 2026
Publication
Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.
Cancer discovery, Jan 2026
Publication
Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
Signal transduction and targeted therapy, Jan 2026
Publication
Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma.
Nature communications, Dec 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Jun Yu directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error